Cargando…
Clinical Aspects of Melatonin Intervention in Alzheimer’s Disease Progression
Melatonin secretion decreases in Alzheimer´s disease (AD) and this decrease has been postulated as responsible for the circadian disorganization, decrease in sleep efficiency and impaired cognitive function seen in those patients. Half of severely ill AD patients develop chronobiological day-night r...
Autores principales: | Cardinali, Daniel P, Furio, Analía M, Brusco, Luis I |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers Ltd
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3001215/ https://www.ncbi.nlm.nih.gov/pubmed/21358972 http://dx.doi.org/10.2174/157015910792246209 |
Ejemplares similares
-
Melatonin Therapy in Patients with Alzheimer’s Disease
por: Cardinali, Daniel P., et al.
Publicado: (2014) -
Melatonin: Clinical Perspectives in Neurodegeneration
por: Cardinali, Daniel P.
Publicado: (2019) -
Melatonin and Its Agonist Ramelteon in Alzheimer's Disease: Possible Therapeutic Value
por: Srinivasan, Venkatramanujam, et al.
Publicado: (2010) -
Melatonin in Alzheimer's disease and other neurodegenerative disorders
por: Srinivasan, V, et al.
Publicado: (2006) -
Melatonin as a Chronobiotic and Cytoprotective Agent in Parkinson’s Disease
por: Pérez-Lloret, Santiago, et al.
Publicado: (2021)